Notes Adnexectomy for Benign Pathology Compared to Laparoscopic Excision
NOTABLE
Adnexectomy for Benign Gynaecological Pathology by Natural Orifice Transluminal Endoscopy or Laparoscopy
1 other identifier
interventional
66
1 country
1
Brief Summary
Objective: To compare vNOTES (vaginal Natural Orifice Transluminal Endoscopic Surgery) and established laparoscopic removal of benign adnexal masses Study design: Randomized controlled/single center/single-blinded/parallel-group/non-inferiority/efficacy trial. Study population: Women aged 18 to 70 years with symptomatic or persistent benign adnexal masses detected by clinical examination and ultrasound. Randomization: Women will be randomly allocated to undergo one of two techniques for removal of the benign adnexal mass immediately before surgery by using a computer generated randomization list. The investigators will use stratified randomization according to the cyst diameter. Intervention: Women will be treated by a surgeon who is not blinded to the treatment allocation and who is equally skilled in performing both techniques. In the intervention group a vNOTES technique will be used. Control: In the control group surgery will be done by a classical laparoscopic technique. Participants, nursing staff and outcome assessors will be blinded. Main study parameters/endpoints: Primary outcomes: successful removal of a benign adnexal mass without spill. Secondary outcomes: the proportion of women discharged the same day based on their own preference; postoperative pain scores using a VAS (Visual Analogue Scale) measured between day 1 till 7 by the participating women following surgery and the total amount of analgesics used as described in the standardized pain treatment protocol between day 1 till 7; postoperative infection defined by lower abdominal pain with fever \> 38°C and positive clinical signs or laboratory findings; per- or postoperative complications according to the Clavien- Dindo classification detected during the first six weeks of surgery; duration of the surgical procedure; incidence and intensity of dyspareunia recorded by the participants at 3 and 6 months by self-reporting using a simple questionnaire and VAS scale; sexual wellbeing recorded by the participants at 3 and 6 months by SSFS (Short Sexual Functioning Scale); direct costs associated up to 6 weeks after the surgical intervention with both procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 8, 2015
CompletedFirst Posted
Study publicly available on registry
December 15, 2015
CompletedStudy Start
First participant enrolled
February 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
April 16, 2020
CompletedJune 11, 2020
June 1, 2020
4.2 years
December 8, 2015
June 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Successful removal of adnexal mass without spill
The proportion of women successfully treated by removing the adnexal mass without spill, using a dichotomous outcome measure, will be used as a measure of efficacy.
Intraoperative
Secondary Outcomes (11)
Discharge from the hospital the day of the surgical intervention
Dichotomous outcome measured on the day of the surgical intervention
Postoperative pain scores
The first week after the surgical intervention
The use of analgesics for postoperative pain
The first week after the surgical intervention
Postoperative infection
The first six weeks after the surgical intervention
Complications
The first six weeks after the surgical intervention
- +6 more secondary outcomes
Study Arms (2)
vNOTES adnexectomy
EXPERIMENTALVaginal Natural Orifice Transluminal Endoscopic Surgery
LSC adnexectomy
ACTIVE COMPARATORLaparoscopic adnexectomy
Interventions
Surgical removal of one or both adnexa by a natural orifice transluminal endoscopic surgical technique using a colpotomy (transvaginal incision)
Surgical removal of one or both adnexa by transabdominal laparoscopy
Eligibility Criteria
You may qualify if:
- All women aged 18 to 70 years regardless of parity with a symptomatic adnexal mass presumed to be benign based on ultrasound examination by applying the IOTA simple rules
- All women aged 18 to 70 years regardless of parity with an asymptomatic persistent adnexal mass presumed to be benign based on ultrasound examination by applying the IOTA simple rules
- Written informed consent obtained prior to surgery
You may not qualify if:
- History of hysterectomy by any technique
- History of rectal surgery
- Suspected rectovaginal endometriosis
- Suspected endometriotic cyst
- Solid adnexal mass
- High suspicion of adnexal malignancy based on clinical, ultrasound or biochemical findings
- History of pelvic inflammatory disease, especially prior tubo-ovarian or pouch of Douglas abscess
- Active lower genital tract infection e.g. Chlamydia, N. gonorrhoeae
- Virgo
- Pregnancy
- Need for other uterine surgical intervention (i.e. endometrial ablation, resection, myomectomy or hysterectomy)
- Additional pathology necessitating hysterectomy
- Failure to provide written informed consent prior to surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Imelda Hospital
Bonheiden, Antwerp, 2820, Belgium
Related Publications (6)
Wang PH, Lee WL, Juang CM, Tsai WY, Chao HT, Yuan CC. Excision of mature teratoma using culdotomy, with and without laparoscopy: a prospective randomised trial. BJOG. 2001 Jan;108(1):91-4. doi: 10.1111/j.1471-0528.2001.00003.x.
PMID: 11213011BACKGROUNDBaekelandt J. Poor man's NOTES: can it be a good approach for adhesiolysis? A first case report with video demonstration. J Minim Invasive Gynecol. 2015 Mar-Apr;22(3):319. doi: 10.1016/j.jmig.2014.11.001. Epub 2014 Nov 10.
PMID: 25460516RESULTYang YS, Hur MH, Oh KY, Kim SY. Transvaginal natural orifice transluminal endoscopic surgery for adnexal masses. J Obstet Gynaecol Res. 2013 Dec;39(12):1604-9. doi: 10.1111/jog.12108. Epub 2013 Jul 22.
PMID: 23875997RESULTGhezzi F, Cromi A, Uccella S, Bogani G, Serati M, Bolis P. Transumbilical versus transvaginal retrieval of surgical specimens at laparoscopy: a randomized trial. Am J Obstet Gynecol. 2012 Aug;207(2):112.e1-6. doi: 10.1016/j.ajog.2012.05.016. Epub 2012 May 23.
PMID: 22704765RESULTMedeiros LR, Rosa DD, Bozzetti MC, Fachel JM, Furness S, Garry R, Rosa MI, Stein AT. Laparoscopy versus laparotomy for benign ovarian tumour. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD004751. doi: 10.1002/14651858.CD004751.pub3.
PMID: 19370607RESULTBaekelandt JF, De Mulder PA, Le Roy I, Mathieu C, Laenen A, Enzlin P, Weyers S, Mol BWJ, Bosteels JJA. Transvaginal natural orifice transluminal endoscopic surgery (vNOTES) adnexectomy for benign pathology compared with laparoscopic excision (NOTABLE): a protocol for a randomised controlled trial. BMJ Open. 2018 Jan 10;8(1):e018059. doi: 10.1136/bmjopen-2017-018059.
PMID: 29326183DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Baekelandt, MD
Imelda Hospital, Bonheiden
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
December 8, 2015
First Posted
December 15, 2015
Study Start
February 3, 2016
Primary Completion
April 16, 2020
Study Completion
April 16, 2020
Last Updated
June 11, 2020
Record last verified: 2020-06
Data Sharing
- IPD Sharing
- Will not share
Interim analyses of major endpoints will be supplied, in strict confidence, to an independent Data Monitoring and Ethics Committee (DMEC) along with updates on results of other related studies, and any other analyses that the DMEC may request.